Immune to Cancer: The CRI Blog
-
CRI’s 7th Annual Patient Immunotherapy Summit – December 2023 Full Cut
The Cancer Research Institute’s 7th Annual Patient Immunotherapy Summit hosts a plethora of impactful information that cancer… -
The Power of Giving: 10 Factors to Consider Before Donating to a Cancer Charity
In 2022 alone, approximately 1.9 million individuals in the United States faced the daunting reality of a… -
Follow Along as Philanthropist Lance Kawaguchi Treks to the South Pole for Cancer Research
There are a variety of ways to raise money for Cancer Research Institute (CRI) to support cancer… -
5 Reasons to Give to CRI Before Year’s End
It is a busy time of year dotted with holidays as 2023 comes to a close. At… -
Give the Gift of Cancer Immunotherapy Research
It is the thick of the holiday season, and you might be thinking of giving generously to… -
Exploring the Different Types of Cancer and Treatment Options
Cancer is a formidable adversary, but our understanding of this disease has come a long way. Cancer… -
Unraveling the Pro-Tumorigenic Myelopoiesis Driven by an IL-4 Signaling Axis in Bone Marrow
CRI is delighted to share the latest milestone achievement from CRI-supported investigators at Icahn School of Medicine… -
CRI Immunologists Are Armed Against Lung Cancer, the Most Common Cancer Worldwide
A Large Cancer Presence on a Global Scale The Cancer Research Institute (CRI) has a singular focus:… -
How CRI is Taking on Pancreatic Cancer, “The Silent Killer”
Immunotherapy holds the greatest promise for optimizing outcomes for cancer patients, and eventually finding a cure for…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.